Scarab Genomics

Scarab Genomics is advancing the future of bioproduction with engineered Clean Genome® E. coli strains. Founded on Dr. Fred Blattner’s groundbreaking E. coli genomics research at the University of Wisconsin–Madison, Scarab was established to commercialize Clean Genome technology—removing mobile DNA elements and unnecessary genes to create safer, more stable, and higher-performing cell factories. Our expanding library of Clean Genome strains delivers superior genetic stability, higher yields, and consistently cleaner products across proteins, peptides, nucleic acids, and scFvs. We also developed C-Flow™, a proprietary continuous fermentation system designed exclusively for Clean Genome strains, enabling steady-state production for weeks or even months, while dramatically accelerating process development and time to market. Whether for research, therapeutic production, or industrial applications, Scarab Genomics provides a more reliable foundation for bioproduction, helping innovators move from discovery to commercialization with greater confidence.